However, apigenin inhibits cisplatin-induced CSC via p53, as A549R cells without p53 and Pifithrin-treatment reduced the drop in CD 133 positive cells following apigenin administration in cisplatin-treated lung cancer cells [120]. The gene discussed is TP53; the disease is lung cancer.